← All companies

NVAX

Novavax, Inc.

NVAX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$7.41

-0.03 -0.40%

Key statistics

from XBRL data in SEC filings

Market cap

$1.22B

Revenue (TTM)

$596M

Net income (TTM)

-$87.8M

EPS (TTM)

$-0.41

P/E ratio

—

Dividend yield

—

Free cash flow

-$302M

Cash

$228M

Total assets

$1.04B

Gross margin

—

52-week range

$6.20 – $11.97

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 23, 2026 8-K Results of operations (earnings release) May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Entered a material agreement Jan 20, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Regulation FD disclosure; Other events Nov 4, 2025 8-K Entered a material agreement; Material impairment; Other events Oct 22, 2025 8-K Regulation FD disclosure; Other events Oct 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 27, 2025 8-K Regulation FD disclosure; Other events Aug 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 21, 2025 8-K Results of operations (earnings release) Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Shareholder vote results Jun 24, 2025 8-K Regulation FD disclosure Jun 11, 2025 8-K Director or officer change May 27, 2025 8-K Regulation FD disclosure; Other events May 19, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Entered a material agreement May 5, 2025 8-K Director or officer change Apr 29, 2025 8-K Regulation FD disclosure Apr 23, 2025 8-K Regulation FD disclosure Apr 2, 2025 8-K Director or officer change; Regulation FD disclosure Mar 11, 2025 8-K Terminated a material agreement Mar 11, 2025 8-K Regulation FD disclosure Mar 4, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Completed an acquisition or disposition Dec 30, 2024 8-K Entered a material agreement Dec 18, 2024 8-K Entered a material agreement Dec 4, 2024 8-K Regulation FD disclosure Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Regulation FD disclosure; Other events Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024